ADAM17 and pulmonary fibrosis: ADAM17 is involved in a variety of inflammatory processes, including activation and release of TNF, modulation of neuregulins such as AREG [39], and being a necessary cofactor for IL6 trans-signaling [33,40], which has been shown to promote pulmonary fibrosis in bleomycin injury [23,41,42].